These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 30678778)

  • 21. Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation.
    Kirubakaran S; Bisceglia C; Silberbauer J; Oloriz T; Santagostino G; Yamase M; Maccabelli G; Trevisi N; Della Bella P
    Europace; 2017 Jun; 19(6):1049-1062. PubMed ID: 28371837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique.
    Berruezo A; Fernández-Armenta J; Mont L; Zeljko H; Andreu D; Herczku C; Boussy T; Tolosana JM; Arbelo E; Brugada J
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):111-21. PubMed ID: 22205683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Freedom From Ventricular Arrhythmias in ARVC With Endocardial Only Ablation: Predictors of Success.
    Chaumont C; Tschabrunn CM; Oraii A; Zado ES; Yogasundaram H; Petzl A; Wasiak M; Rodriguez-Queralto O; Lopez-Martinez H; Markman TM; Kumareswaran R; Dixit S; Garcia FC; Lin D; Riley MP; Supple GE; Hyman MC; Nazarian S; Callans DJ; Frankel DS; Anselme F; Marchlinski FE
    JACC Clin Electrophysiol; 2024 Jul; 10(7 Pt 2):1551-1561. PubMed ID: 38869508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substrate Characterization and Outcome of Catheter Ablation of Ventricular Tachycardia in Patients With Nonischemic Cardiomyopathy and Isolated Epicardial Scar.
    Liuba I; Muser D; Chahal A; Tschabrunn C; Santangeli P; Kuo L; Frankel DS; Callans DJ; Garcia F; Supple GE; Schaller RD; Dixit S; Lin D; Nazarian S; Kumareswaran R; Arkles J; Riley MP; Hyman MC; Walsh K; Guandalini G; Arceluz M; Pothineni NVK; Zado ES; Marchlinski F
    Circ Arrhythm Electrophysiol; 2021 Dec; 14(12):e010279. PubMed ID: 34847692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Larger low voltage zone in endocardial unipolar map compared with that in epicardial bipolar map indicates difficulty in eliminating ventricular tachycardia by catheter ablation.
    Miyamoto K; Noda T; Satomi K; Wada M; Nakajima I; Ishibashi K; Okamura H; Noguchi T; Anzai T; Yasuda S; Ogawa H; Shimizu W; Aiba T; Kamakura S; Kusano K
    Heart Vessels; 2016 Aug; 31(8):1337-46. PubMed ID: 26266635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry.
    Souissi Z; Boulé S; Hermida JS; Doucy A; Mabo P; Pavin D; Anselme F; Auquier N; Ninni S; Coisne A; Brigadeau F; Deken-Delannoy V; Klug D; Lacroix D
    Europace; 2018 Feb; 20(2):362-369. PubMed ID: 28017936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease.
    Kumar S; Romero J; Mehta NK; Fujii A; Kapur S; Baldinger SH; Barbhaiya CR; Koplan BA; John RM; Epstein LM; Michaud GF; Tedrow UB; Stevenson WG
    Heart Rhythm; 2016 Oct; 13(10):1957-63. PubMed ID: 27392945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VT Recurrence After Ablation: Incomplete Ablation or Disease Progression? A Multicentric European Study.
    Berte B; Sacher F; Venlet J; Andreu D; Mahida S; Aldhoon B; DE Potter T; Sarkozy A; Tavernier R; Andronache M; Deneke T; Kautzner J; Berruezo A; Cochet H; Zeppenfeld K; Jaïs P
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):80-7. PubMed ID: 26471955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.
    Bai R; Di Biase L; Shivkumar K; Mohanty P; Tung R; Santangeli P; Saenz LC; Vacca M; Verma A; Khaykin Y; Mohanty S; Burkhardt JD; Hongo R; Beheiry S; Dello Russo A; Casella M; Pelargonio G; Santarelli P; Sanchez J; Tondo C; Natale A
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):478-85. PubMed ID: 21665983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond the Storm: Comparison of Clinical Factors, Arrhythmogenic Substrate, and Catheter Ablation Outcomes in Structural Heart Disease Patients With versus Those Without a History of Ventricular Tachycardia Storm.
    Kumar S; Fujii A; Kapur S; Romero J; Mehta NK; Tanigawa S; Epstein LM; Koplan BA; Michaud GF; John RM; Stevenson WG; Tedrow UB
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):56-67. PubMed ID: 27781325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study.
    Berruezo A; Acosta J; Fernández-Armenta J; Pedrote A; Barrera A; Arana-Rueda E; Bodegas AI; Anguera I; Tercedor L; Penela D; Andreu D; Perea RJ; Prat-González S; Mont L
    Europace; 2017 Apr; 19(4):607-616. PubMed ID: 28431051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ablation strategies for arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis.
    Shen LS; Liu LM; Zheng LH; Hu F; Hu ZC; Liu SY; Guo JR; Bhagat KK; Yao Y
    J Geriatr Cardiol; 2020 Nov; 17(11):694-703. PubMed ID: 33343648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia.
    Nakahara S; Tung R; Ramirez RJ; Michowitz Y; Vaseghi M; Buch E; Gima J; Wiener I; Mahajan A; Boyle NG; Shivkumar K
    J Am Coll Cardiol; 2010 May; 55(21):2355-65. PubMed ID: 20488307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Philips B; te Riele AS; Sawant A; Kareddy V; James CA; Murray B; Tichnell C; Kassamali B; Nazarian S; Judge DP; Calkins H; Tandri H
    Heart Rhythm; 2015 Apr; 12(4):716-25. PubMed ID: 25530221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Garcia FC; Bazan V; Zado ES; Ren JF; Marchlinski FE
    Circulation; 2009 Aug; 120(5):366-75. PubMed ID: 19620503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infarct transmurality as a criterion for first-line endo-epicardial substrate-guided ventricular tachycardia ablation in ischemic cardiomyopathy.
    Acosta J; Fernández-Armenta J; Penela D; Andreu D; Borras R; Vassanelli F; Korshunov V; Perea RJ; de Caralt TM; Ortiz JT; Fita G; Sitges M; Brugada J; Mont L; Berruezo A
    Heart Rhythm; 2016 Jan; 13(1):85-95. PubMed ID: 26165946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ablation compared with drug therapy for recurrent ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: Results from a multicenter study.
    Mahida S; Venlet J; Saguner AM; Kumar S; Baldinger SH; AbdelWahab A; Tedrow UB; Castelletti S; Pantazis A; John RM; McKenna WJ; Lambiase PD; Duru F; Sapp JL; Zeppenfeld K; Stevenson WG
    Heart Rhythm; 2019 Apr; 16(4):536-543. PubMed ID: 30366162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catheter ablation of arrhythmogenic right ventricular cardiomyopathy ventricular tachycardia: 18-year experience in 284 patients.
    Liang E; Wu L; Fan S; Hu F; Zheng L; Liu S; Fan X; Chen G; Ding L; Niu G; Yao Y
    Europace; 2020 May; 22(5):806-812. PubMed ID: 32155249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types.
    Oloriz T; Silberbauer J; Maccabelli G; Mizuno H; Baratto F; Kirubakaran S; Vergara P; Bisceglia C; Santagostino G; Marzi A; Sora N; Roque C; Guarracini F; Tsiachris D; Radinovic A; Cireddu M; Sala S; Gulletta S; Paglino G; Mazzone P; Trevisi N; Della Bella P
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):414-23. PubMed ID: 24785410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy.
    Basu-Ray I; Khanra D; Shah SK; Mukherjee A; Char SV; Jain B; Bunch TJ; Gold M; Adeboye AA; Saeed M
    Pacing Clin Electrophysiol; 2021 Jan; 44(1):54-62. PubMed ID: 33216394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.